$LOGQ
Coyni, Inc.

2023 Q4 Form 10-Q Financial Statement

#000118518523001192 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $24.10K $38.42K $18.98K
YoY Change -29.72% 102.4% 1.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $24.10K $38.42K $18.98K
YoY Change -29.72% 102.4% 1.29%
Operating Profit -$38.42K -$18.98K
YoY Change 102.4% 1.31%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$24.10K -$38.42K -$18.98K
YoY Change -29.72% 102.42% -80.89%
Income Tax
% Of Pretax Income
Net Earnings -$24.10K -$38.42K -$18.98K
YoY Change -29.72% 102.4% -80.89%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 100.3M shares 100.3M shares 2.302M shares
Diluted Shares Outstanding 100.3M shares 2.302M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $2.010K $510.00 $710.00
YoY Change 294.12% -28.17% -57.23%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.011K $511.00 $711.00
YoY Change 293.54% -28.13% -57.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.011K $511.00 $711.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $2.011K $511.00 $711.00
YoY Change 293.54% -28.13% -57.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $76.71K $78.51K $13.99K
YoY Change 164.85% 461.0% -99.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $158.8K $133.2K $13.99K
YoY Change 448.47% 852.15% -99.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $158.8K $133.2K $13.99K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $158.9K $133.2K $13.99K
YoY Change 448.52% 852.39% -99.78%
SHAREHOLDERS EQUITY
Retained Earnings -$29.58M -$29.56M -$29.20M
YoY Change 1.2% 1.23%
Common Stock $101.3K $100.3K $2.302K
YoY Change 4300.61% 4257.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$156.8K -$132.7K -$13.28K
YoY Change
Total Liabilities & Shareholders Equity $2.011K $511.00 $711.00
YoY Change 293.54% -28.13% -57.17%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$24.10K -$38.42K -$18.98K
YoY Change -29.72% 102.4% -80.89%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 $0.00 $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 0.000 0.000 0.000
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash 0.000 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00 $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NONE
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-22711
dei Entity Registrant Name
EntityRegistrantName
COYNI, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0640970
dei Entity Address Address Line1
EntityAddressAddressLine1
3131 Camino Del Rio N, Suite 1400
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92108
dei City Area Code
CityAreaCode
(855)
dei Local Phone Number
LocalPhoneNumber
201-1613
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Security12b Title
Security12bTitle
N/A
dei Trading Symbol
TradingSymbol
N/A
dei Entity Shell Company
EntityShellCompany
true
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
100301968 shares
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
511 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
511 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
511 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
511 usd
CY2023Q3 us-gaap Assets
Assets
511 usd
CY2022Q4 us-gaap Assets
Assets
511 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78506 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28962 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
54738 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
133244 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28962 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9999942 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9999942 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100301968 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100301968 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100301968 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100301968 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
100302 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2302 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29322475 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29198773 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29555510 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29229526 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-132733 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-28451 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
511 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
511 usd
us-gaap Share Based Compensation
ShareBasedCompensation
221702 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
104282 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59798 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38419 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18982 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-325984 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-59798 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-38419 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18982 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
133004 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
0 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-133004 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-325984 usd
us-gaap Net Income Loss
NetIncomeLoss
-192802 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-38419 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-18982 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79070719 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2301968 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100301968 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2301968 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-28451 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276226 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
221702 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-82975 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11339 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-94314 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-38419 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-132733 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6512191 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-99397 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-6611588 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-74423 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
5577937 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1108074 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-18982 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1113773 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-13283 usd
us-gaap Net Income Loss
NetIncomeLoss
-325984 usd
us-gaap Net Income Loss
NetIncomeLoss
-192802 usd
us-gaap Share Based Compensation
ShareBasedCompensation
221702 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-779 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
104282 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
192023 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
logq Assignment Of Thirdparty Liabilities To A Related Party
AssignmentOfThirdpartyLiabilitiesToARelatedParty
0 usd
logq Assignment Of Thirdparty Liabilities To A Related Party
AssignmentOfThirdpartyLiabilitiesToARelatedParty
5577937 usd
logq Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
0 usd
logq Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
6691710 usd
logq Operating Expenses Directly Paid By A Related Party
OperatingExpensesDirectlyPaidByARelatedParty
54738 usd
logq Operating Expenses Directly Paid By A Related Party
OperatingExpensesDirectlyPaidByARelatedParty
63694 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration:underline">SIGNIFICANT ESTIMATES</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the periods. We considered the potential impact of the COVID-19 pandemic on our estimates and assumptions and there was not a material impact to our financial statements as of September 30, 2023 and December 31, 2022, and for the nine and three months ended September 30, 2023 and 2022. Actual results could differ from estimates making it reasonably possible that a change in the estimates could occur in the near term.</p>
us-gaap Net Income Loss
NetIncomeLoss
-325984 usd
us-gaap Net Income Loss
NetIncomeLoss
-192802 usd
CY2023Q3 logq Working Capital Deficit
WorkingCapitalDeficit
-132733 usd
CY2022Q4 logq Working Capital Deficit
WorkingCapitalDeficit
-28451 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-132733 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-28451 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2355395 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
39083 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
28962 usd
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
39423 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
0 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78506 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28962 usd
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2355395 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2333496 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2333496 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
9108809 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
2107360 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
98000000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
221702 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
200 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000768216

Files In Submission

Name View Source Status
0001185185-23-001192-index-headers.html Edgar Link pending
0001185185-23-001192-index.html Edgar Link pending
0001185185-23-001192.txt Edgar Link pending
0001185185-23-001192-xbrl.zip Edgar Link pending
coyni20230930_10q.htm Edgar Link pending
ex_594789.htm Edgar Link pending
ex_594790.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
coyni20230930_10q_htm.xml Edgar Link completed
logq-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
logq-20230930_cal.xml Edgar Link unprocessable
logq-20230930_def.xml Edgar Link unprocessable
logq-20230930_lab.xml Edgar Link unprocessable
logq-20230930_pre.xml Edgar Link unprocessable